Latest news

MEDICAL DEVICE FOR
THE PREVENTION
AND
THERAPY OF MALARIA:
QR’EM ORANGE

 

Listen here:

 

 

QR’EM ORANGE: An In-Depth Overview

I. QR’EM ORANGE Medical Device Leaflet:

A. Description and Use: This section introduces QR’EM ORANGE, an electromagnetic medical device designed to support antimalarial therapies by optimizing and speeding up their pharmacological action. It emphasizes that QR’EM ORANGE does not replace conventional antimalarial drugs

B. Mechanism of Action: This section details how QR’EM ORANGE works. It explains that the device utilizes a potential difference between the skin and the device to release ionic charges and generate low-intensity electromagnetic signals via Quantum Dots. These signals selectively disrupt the Plasmodium parasite, making it more susceptible to antimalarial drugs.

C. Composition and Activities: This section outlines the composition of the QR’EM ORANGE device, highlighting the absence of nickel and latex. It further explains the device’s mode of action, stating that it induces biological effects in the Plasmodium parasite through the delocalization of ionic charges and photon emissions.

D. Benefits and Usage: This section summarizes the benefits of using QR’EM ORANGE, including progressive improvement within the first week, continuous usage based on individual needs, and compatibility with antimalarial tests. It emphasizes the device’s safety, stating that it does not cause known side effects or interfere with cardiac activity.

E. Instructions and Warnings: This section provides step-by-step instructions on how to apply the bracelet and patch components of QR’EM ORANGE. It also lists warnings and contraindications, including avoiding use on damaged skin, keeping the device away from children, and potential allergic reactions.

F. Handling and Maintenance: This section advises users to maintain high levels of hydration, especially during the first week of use. It also recommends cleaning the device with water and non-aggressive detergents and cautions against the use of certain creams and perfumes that may damage the device.

II. QR’EM ORANGE Clinical Study Protocol:

A. Study Title and Information: This section details the study’s title, protocol code, sponsor, clinical phase, study site, and principal investigators.

B. Introduction and Background: This section provides background information on malaria, highlighting its global impact and emphasizing the need for effective treatments. It introduces the concept of Holographic Information Transfer (H.I.T.) technology and explains how QR’EM ORANGE utilizes this technology.

C. Study Objectives and Design: This section outlines the primary and secondary objectives of the clinical study, which are to evaluate the clinical efficacy and safety of QR’EM ORANGE in patients with uncomplicated malaria. It also describes the study design, a post-marketing interventional study with one treatment and a week of evaluation.

D. Study Population and Criteria: This section specifies the target population, including inclusion criteria such as age, malaria diagnosis, and no prior antimalarial medication, and exclusion criteria such as severe malaria, recent antimalarial use, and pregnancy.

E. Study Conduct and Procedures: This section details the study duration, phases, and specific procedures to be performed at each phase, including informed consent, medical history, vital signs, and device administration. It outlines the data collection process, highlighting the use of microscopic readings to assess the number of parasites in patient blood samples.

F. Study Drug and Administration: This section describes the study drug (QR’EM ORANGE) and its administration, specifying the dosage (two patches per patient) and location of application (liver area and inner side of the wrist).

G. Safety and Pharmacovigilance: This section outlines the procedures for monitoring and reporting adverse events, including their definition, classification by severity, and reporting procedures for serious adverse events.

H. Statistical Methodology: This section describes the planned statistical analysis, including sample size calculation, primary and secondary endpoints, analysis sets, and methods for handling missing data.

I. Regulatory and Ethical Considerations: This section addresses regulatory and ethical aspects of the study, including compliance with good clinical practice guidelines, informed consent procedures, criteria for patient withdrawal, and premature discontinuation of the trial.

J. Documentation and Monitoring: This section outlines the documentation requirements for the study, including site documentation, sponsor-supplied documents, record maintenance, and data management procedures. It also describes the monitoring process, including responsibilities of the study monitors and procedures for ensuring data quality.

K. Use of Information and Publication: This section addresses the use of study information, emphasizing confidentiality of patient data and the procedures for publication of study results.

L. Investigator’s Agreement: This section includes a statement of agreement from the investigators, confirming their understanding and commitment to adhering to the study protocol.

III. QR’EM ORANGE Risk Analysis:

A. Risk Assessment: This document provides a detailed risk assessment table that identifies potential hazards associated with the QR’EM ORANGE device, their probability of occurrence, severity, and proposed mitigation strategies.

IV. QR’EM ORANGE Statistical Analysis:

A. Data Analysis and Results: This section presents the statistical analysis results from the clinical study, including demographic data of participants, effectiveness of the device in reducing malaria parasite counts, and statistical significance of the findings.

B. Data Visualization: This section incorporates graphs and tables to visually represent the study data, including the distribution of participants by origin and sex, and the change in parasite levels over time.

C. Study Conclusions: This section summarizes the main findings of the study, highlighting the positive results observed in reducing malaria parasite counts and concluding that QR’EM ORANGE shows potential as a valuable tool for malaria treatment.

V. Holographic Information Transfer Technology:

A. Introduction to H.I.T.: This section introduces the concept of Holographic Information Transfer (H.I.T.) technology, developed by Dario Maximilian Spera. It explains the principle behind H.I.T. and how it utilizes the electromagnetic activity of molecules to induce biological effects.

B. Applications of H.I.T.: This section highlights the diverse applications of H.I.T. technology, including its use in medical devices for various conditions such as inflammation, pain, and tissue regeneration. It also mentions its potential in agriculture and industrial applications.

C. Research and Development: This section details the research and development efforts behind H.I.T., emphasizing collaborations with universities and research institutions. It mentions the Medical CE marking obtained for H.I.T. devices and their commercialization in various markets.

D. QR’EM ORANGE for Malaria: This section focuses specifically on the application of H.I.T. in developing QR’EM ORANGE for malaria treatment. It describes the promising results obtained in clinical trials in Nigeria and Cameroon, demonstrating the device’s effectiveness in eradicating malaria parasites within a week.

E. Future Directions: This section outlines the future plans for H.I.T. and QR’EM ORANGE, including expanding clinical trials to other countries, exploring applications for other diseases like GVHD and autoimmune pathologies, and investigating its potential in oncology.

VI. Malaria Overview and Prevention:

A. Malaria Basics: This section provides a concise overview of malaria, including its transmission, symptoms, and the Plasmodium parasite species responsible for different forms of the disease.

B. Malaria Prophylaxis: This section focuses on malaria prevention, discussing both behavioral and pharmacological prophylaxis strategies. It emphasizes the importance of seeking medical advice and taking appropriate preventive measures when traveling to malaria-endemic areas.

C. QR’EM ORANGE for Malaria Prophylaxis: This section specifically highlights the use of QR’EM ORANGE as a prophylactic measure against malaria. It outlines the recommended usage instructions, suggesting wearing the device for at least three weeks before, during, and after travel to endemic areas.

This table of contents provides a comprehensive framework for understanding the key information presented in the provided source materials, offering an in-depth overview of QR’EM ORANGE, H.I.T. technology, malaria, and related clinical research.

 

QR’EM ORANGE FAQ

What is QR’EM ORANGE?

QR’EM ORANGE is an electromagnetic medical device designed to support standard antimalarial drug therapies. It consists of a bracelet worn on the left wrist and a patch applied to the skin over the liver area.

How does QR’EM ORANGE work?

QR’EM ORANGE utilizes the principles of Holographic Information Transfer (H.I.T.) technology. Through a combination of ionic charges and low-intensity electromagnetic signals emitted by Quantum Dots, it creates a “jamming frequency” within the body. This frequency disrupts the Plasmodium parasite’s cellular processes, weakening it and making it more susceptible to the effects of antimalarial medications.

Does QR’EM ORANGE replace antimalarial drugs?

No, QR’EM ORANGE is not a replacement for prescribed antimalarial medications. It is designed to work as an adjuvant therapy, enhancing the effectiveness of traditional treatments.

What is the scientific basis for QR’EM ORANGE’s effectiveness?

The technology is grounded in the principles of applied quantum physics and utilizes advancements in nanomaterials. It targets and alters the ionic exchange and redox processes within the Plasmodium parasite, creating an environment hostile to its survival.

What are the benefits of using QR’EM ORANGE?

QR’EM ORANGE has shown promising results in clinical trials. It can potentially:

  • Optimize and accelerate the action of antimalarial drugs.
  • Reduce the duration of treatment needed.
  • Improve overall treatment outcomes.

Are there any side effects or contraindications?

QR’EM ORANGE is generally safe for use and does not cause any known side effects. However, there are some contraindications, including:

  • Damaged or injured skin at the application site
  • Known allergies to device components
  • Pregnancy or breastfeeding

What are the instructions for using QR’EM ORANGE?

  1. Apply the bracelet to clean, dry skin on your left wrist, ensuring a snug but comfortable fit.
  2. Apply the patch to clean, dry skin over the liver area using the provided adhesive.
  3. Wear both the bracelet and patch continuously for three weeks for optimal results.
  4. Maintain adequate hydration throughout the treatment period.

Where can I find more information about QR’EM ORANGE?

More detailed information, including clinical study data, risk analysis, and scientific publications can be found in the accompanying documents:

  • QR’EM ORANGE Leaflet
  • Clinical Study Protocol
  • Risk Analysis Report
  • Statistical Analysis Report
  • Holographic Information Transfer Documentation
  • Malaria Overview Presentation